Ilan Melnick
Psychiatry · Coral Gables, FLNPI 1427048115
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,063,240 of the $2,829,789 with a category attached, or 72.9%. 36 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 24.4% of the total. 2025 is the largest year on record at $813,000, 2.3 times the $347,546 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3,328 payments — averaging $850.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$690K
- Neurocrine Biosciences, Inc.$655K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$339K
- Teva Pharmaceuticals USA, Inc.$299K
- Axsome Therapeutics, Inc.$204K
- E.r. Squibb & Sons, L.L.C.$167K
- plus $476K from 30 others
What the payments were for
- Consulting fees$327,86212%
- Speaking & faculty fees$2,063,24073%
- Travel & lodging$366,18213%
- Food & beverage$72,2533%
- Education$2510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$639,328
- ARISTADA$497,523
- REXULTI$411,905
- ABILIFY MAINTENA$367,259
- CAPLYTA$335,987
- UZEDY$204,862
- Auvelity$200,285
- ABILIFY ASIMTUFII$145,281
- ARISTADA INITIO$123,809
- LYBALVI$119,058
- COBENFY$111,439
- Austedo XR$83,607
- VRAYLAR$31,014
- PERSERIS$30,376
- LATUDA$26,063
- BRINTELLIX$23,246
- SECUADO$19,891
- Fanapt$19,451
- Dayvigo$10,830
- Xelstrym$9,546
How this compares
$2,829,789 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UzedyRisperidone | 57 | $192,400 |
| Austedo XrDeutetrabenazine | 18 | $162,997 |
| Invega SustennaPaliperidone Palmitate | 26 | $77,608 |
| RexultiBrexpiprazole | 31 | $45,257 |
| AristadaAripiprazole Lauroxil | 13 | $41,469 |
| OzempicSemaglutide | 31 | $38,673 |
| EmsamSelegiline | 13 | $26,751 |
| TrintellixVortioxetine Hydrobromide | 58 | $26,472 |
| CaplytaLumateperone Tosylate | 12 | $20,606 |
| SeroquelQuetiapine Fumarate | 17 | $14,974 |
| Olanzapine OdtOlanzapine | 48 | $10,120 |
| Fluphenazine Hcl | 36 | $10,048 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 47 | $9,743 |
| Divalproex Sodium ErDivalproex Sodium | 76 | $8,281 |
| Lamotrigine OdtLamotrigine | 12 | $7,216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Uzedy, Austedo Xr | $299,421 | $355,39775 claims |
| Johnson & JohnsonInvega Sustenna | $1,266 | $77,60826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $690,115 | $45,25731 claims |
| Alkermes, Inc.Aristada | $157,250 | $41,46913 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $9,750 | $26,47258 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $339,059 | $20,60612 claims |
| Eisai Inc.Dayvigo | $10,902 | $4,65914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Coral Gables
- Moraima TrujilloCoral Gables$121K
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.